Articles by : Bella Czajkowski, National Correspondent

Tariffs on Pharmaceuticals Could Worsen Drug Shortages, Cause Disarray in 340B Prices, Advocates Say

April 17, 2025 Bella Czajkowski, National Correspondent Views

President Trump said he will implement tariffs on pharmaceuticals in the “not too distant future.” Many of the details of these potential tariffs remain unknown.

President Donald Trump’s (R) plan to place tariffs on foreign pharmaceuticals could destabilize 340B drugs’ prices unless drugmakers absorb the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: 5th Circuit Appeals in Louisiana, 4th Circuit Appeal in West Virginia

April 17, 2025 Shannon Young and Bella Czajkowski, Associate Editor/Senior Writer Views

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Louisiana.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

SK Life Science Announces 340B Refunds for Epilepsy Treatment

April 15, 2025 Bella Czajkowski, National Correspondent Views

New Jersey-based SK Life Science announced refunds for 340B covered entities that purchased certain formulations of anti-seizure drug XCOPRI.

SK Life Science recently issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. The New [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J Adds Unbranded Version of Stelara to 340B Contract Pharmacy Restrictions

April 10, 2025 Bella Czajkowski, National Correspondent Views

J&J has added the unbranded version of its top-selling psoriatic arthritis treatment Stelara to its 340B contract pharmacy restrictions.

Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Closed Pennsylvania Hospital Revives 340B Antitrust Lawsuit Against CVS’ TPA Wellpartner

April 8, 2025 Bella Czajkowski, National Correspondent Views

Brandywine Hospital amended its legal filing in a class action case against a CVS contract pharmacy policy.

A shuttered Philadelphia-area hospital recently amended its legal filing in a class action case against CVS Health’s (CVS) contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: 4th Circuit Appeals in West Virginia, Maryland

April 3, 2025 Bella Czajkowski, National Correspondent Views

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Maryland.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Virginia Governor Signs Bill Protecting 340B Hospitals from PBM Discrimination

March 27, 2025 Bella Czajkowski, National Correspondent Views

Virginia Gov. Glenn Youngkin (R) signed a bill on March 24 to expand the state's existing 340B PBM anti-discrimination law to also apply to hospitals.

Virginia Gov. Glenn Youngkin (R) signed a bill this week that will expand the state’s existing 340B pharmacy benefit manager [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck is First to Exempt South Dakota from 340B Contract Pharmacy Restrictions but Reinstates in Kansas, Novartis Exempts Missouri

March 25, 2025 Bella Czajkowski, National Correspondent Views

Merck announced it will exempt South Dakota from its contract pharmacy restrictions and reinstate them in Kansas. Novartis will exempt Missouri from its contract pharmacy restrictions.

Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Trump’s HHS Continues to Oppose Unilateral Drugmaker 340B Rebates in Kalderos Lawsuit

March 20, 2025 Bella Czajkowski, National Correspondent Views

HHS filed a motion for summary judgement against Kalderos, the drug industry vendor behind Eli Lilly’s rebate proposal.

The Trump administration this week continued to oppose drug industry attempts to unilaterally convert 340B discounts to a rebate model, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Nominee ‘Dr. Oz’ Grilled Over Potential Medicaid Cuts and Position on Medicare Negotiations at Confirmation Hearing

March 18, 2025 Bella Czajkowski, National Correspondent Views

The Senate Finance Committee pressed Mehmet Oz, known as "Dr. Oz," on whether he would oppose cuts to Medicaid as CMS administrator. Oliver Oz, his son who is marketed as having a leadership role at a 340B services company, sat behind him during the hearing.

Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live